CXCR4 and posterior cortical atrophy: Thus targeting CXCR4 (C-X-C chemokine receptor type 4)/let-7 mediated IGF2BP1 induction in PCSCs by Berbamine could restore PCa response to cabazitaxel treatment (Wang et al., 2024).